Augmented expression of CD44 splice variants in lymphoproliferative disorder of the lacrimal gland in Sjogren's syndrome

Japanese Journal of Ophthalmology

Volumn 41, Issue 5, 1997, Pages 312-318

  Hiraoka, Miki ^a   Saito, Ichiro ^a   Tsubota, Kazuo ^b   Sugai, Susumu ^c   Miyasaka, Nobuyuki ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CD44 splice variant; Lacrimal gland; Lymphoproliferative disorder; Sjogren's syndrome

Indexed keywords

HERMES ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; EXON; FEMALE; HUMAN; HUMAN CELL; LACRIMAL GLAND DISEASE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ANTIGENS, CD44; DNA PRIMERS; DNA PROBES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LACRIMAL APPARATUS; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA; RNA SPLICING; RNA, MESSENGER; SJOGREN'S SYNDROME;

EID: 0030665392     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(97)00072-5     Document Type: Article

References (26)

1. Font RL. Yanoff M, Zimmerman LE. Benign lymphoepithelial lesion of the lacrimal gland and its relationship to Sjögren's syndrome. Am J Clin Pathol 1967;48:365-76.
2. McCurley TL, Collins RD, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjögren's syndrome: A clinical and immunopathologic study. Hum Pathol 1990;21:482-92.
3. Pavlidis NA, Drosos AA, Papadimitriou C, Talal N, Moutsopoulos HM. Lymphoma in Sjögren's syndrome. Med Ped Oncol 1992;20:279-83.
4. Jalkanen S, Bargatze RF, Herron LR, Butcher EC. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986;16:1195-1202.
5. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
6. Huet S, Groux H, Caillou B, et al. CD44 contributes to T cell activation. J Immunol 1989;143:798-801.
7. Goldstein LA, Zhou DFH, Picker LJ, et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989;56: 1063-72.
8. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
9. Culty M, Miyake K, Kincade PW, et al. The hyaluronate receptor is a member of the CD44(H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111:2765-74.
10. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
11. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267:4732-9.
12. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci 1992;89:12160-4.
13. Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21:1225-9.
14. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340: 1053-8.
15. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
16. Matzku S, Wenzel A, Liu S, Zöller M. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 1989; 49:1294-9.
17. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993;177:443-55.
18. Koopman G, Heider KH, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993;177:897-904.
19. Schall GL, Anderson LG, Wolf RO, et al. Xerostomia in Sjögren's syndrome: Evaluation by sequential salivary scintigraphy. JAMA 1971;216:2109-16.
20. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
21. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol Suppl 1986; 61:26-7.
22. Takeshita S, Sugai S, Ogawa Y, et al. A case of Sjögren's syndrome with an eyelid tumor, a so-termed pseudolymphoma of the lacrimal gland. Ryumachi (Rheumatism) 1996;36:43-9.
23. Fox SB, Fawcett J, Jackson DG, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994;54:4539-46.
24. Adamson TC, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983; 130: 203-8.
25. Heider KH, Hofmann M, Hors E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. Cell Biol 1993;120:227-33.
26. Mulder JWR, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;344:1470-2.